Fetal arrhythmia: Prenatal diagnosis and perinatal management

The importance of managing fetal arrhythmia has increased over the past three decades. Although most fetal arrhythmias are benign, some types cause fetal hydrops and can lead to fetal death. With the aim of improving the outcome in such cases, various studies for prenatal diagnosis and perinatal management have been published. Detailed analysis of the type of arrhythmia in utero is possible using M‐mode and Doppler echocardiography. In particular, a simultaneous record of Doppler waveform at the superior venous cava and the ascending aorta has become an important and useful method of assessing the interval between atrial and ventricular contractions. Common causes of fetal tachycardia (ventricular heart rate faster than 180 bpm), are paroxysmal supraventricular tachycardia (SVT) with 1:1 atrioventricular (AV) relation and atrial flutter with 2:1 AV relation. Of fetal SVT, short ventriculo‐atrial (VA) interval tachycardia due to atrioventricular reentrant tachycardia is more common than long VA interval. Most fetuses with tachycardia are successfully treated in utero by transplacental administration of antiarrhythmic drugs. Digoxin is widely accepted as a first‐line antiarrhythmic drug. Sotalol, flecainide and amiodarone are used as second‐line drugs when digoxin fails to achieve conversion to sinus rhythm. Fetal bradycardia is diagnosed when the fetal ventricular heart rate is slower than 100 bpm, mainly due to AV block. Approximately half of all cases are caused by associated congenital heart disease, and the remaining cases that have normal cardiac structure are often caused by maternal SS‐A antibody. The efficacy of prenatal treatment for fetal AV block is limited compared with treatment for fetal tachycardia. Beta stimulants and steroids have been reported as effective transplacental treatments for fetal AV block. Perinatal management based on prospective clinical study protocol rather than individual experience is crucial for further improvement of outcome in fetuses with tachycardia and bradycardia.

[1]  J. Hobbins,et al.  Echocardiographic studies of the human fetus: prenatal diagnosis of congenital heart disease and cardiac dysrhythmias. , 1980, Pediatrics.

[2]  F. Kubli,et al.  [Fetal arrhythmia]. , 1984, Zeitschrift fur Geburtshilfe und Perinatologie.

[3]  L. Shenker Fetal arrhythmias. , 1987, Journal of the American College of Cardiology.

[4]  N. Silverman,et al.  Perinatal outcome of fetal complete atrioventricular block: a multicenter experience. , 1991, Journal of the American College of Cardiology.

[5]  U. Gembruch,et al.  Longitudinal study in 18 cases of fetal supraventricular tachycardia: Doppler echocardiographic findings and pathophysiologic implications. , 1993, American heart journal.

[6]  P. Stewart,et al.  Clinical significance of maternal anti-Ro/SS-A antibodies in children with isolated heart block. , 1994, Journal of the American College of Cardiology.

[7]  J. Brenner,et al.  Management outcome and follow-up of fetal tachycardia. , 1994, Journal of the American College of Cardiology.

[8]  J. Buyon,et al.  Successful in utero therapy of fetal heart block. , 1995, American journal of obstetrics and gynecology.

[9]  E. Rosenthal,et al.  Therapeutic trial of sympathomimetics in three cases of complete heart block in the fetus. , 1995, Circulation.

[10]  S. Gidding,et al.  Fetal tachycardia: mechanisms and predictors of hydrops fetalis. , 1996, Journal of the American College of Cardiology.

[11]  E. Rosenthal,et al.  Outcome of isolated congenital complete heart block diagnosed in utero. , 1996, Heart.

[12]  U. Gembruch,et al.  Venous blood flow pattern suggesting tachycardia‐induced ‘cardiomyopathy’ in the fetus , 1997, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[13]  M. Hofbeck,et al.  Prenatal findings in patients with prolonged QT interval in the neonatal period. , 1997, Heart.

[14]  J. Simpson,et al.  Outcome of Intermittent Tachyarrhythmias in the Fetus , 1997, Pediatric Cardiology.

[15]  M. Druzin,et al.  A NEW THERAPEUTIC APPROACH TO THE FETUS WITH CONGENITAL COMPLETE HEART BLOCK: PREEMPTIVE, TARGETED THERAPY WITH DEXAMETHASONE , 1998, Obstetrics and gynecology.

[16]  M. Burch,et al.  Echocardiography in Pediatric Heart Disease. , 1998 .

[17]  J. Simpson,et al.  Fetal tachycardias: management and outcome of 127 consecutive cases , 1998, Heart.

[18]  E. Jaeggi,et al.  Ventriculo-atrial time interval measured on M mode echocardiography: a determining element in diagnosis, treatment, and prognosis of fetal supraventricular tachycardia , 1998, Heart.

[19]  D. Friedman,et al.  Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. , 1998, Journal of the American College of Cardiology.

[20]  E. Jaeggi,et al.  Fetal atrial flutter: diagnosis, clinical features, treatment, and outcome. , 1998, The Journal of pediatrics.

[21]  S. Miyagawa,et al.  Neonatal lupus erythematosus: results of maternal corticosteroid therapy. , 1999, Obstetrics and gynecology.

[22]  G. Visser,et al.  Sotalol in the treatment of fetal dysrhythmias. , 2000, Circulation.

[23]  J. Brenner,et al.  Atrial flutter in the perinatal age group: diagnosis, management and outcome. , 2000, Journal of the American College of Cardiology.

[24]  B. Cuneo,et al.  Management Strategy for Fetal Tachycardia , 2000, Obstetrics and gynecology.

[25]  J. Fouron,et al.  Correlation between Electrocardiographic and Ultrasonographic Time-Interval Measurements in Fetal Lamb Heart , 2000, Pediatric Research.

[26]  T. Cordes,et al.  Second-Line Treatment of Fetal Supraventricular Tachycardia Using Flecainide Acetate , 2001, Pediatric Cardiology.

[27]  M. I. Cohen,et al.  Dilated cardiomyopathy in isolated congenital complete atrioventricular block: early and long-term risk in children. , 2001, Journal of the American College of Cardiology.

[28]  R. Friedman,et al.  Congenital heart block: development of late-onset cardiomyopathy, a previously underappreciated sequela. , 2001, Journal of the American College of Cardiology.

[29]  J. Cotton Identification of fetal atrial flutter by Doppler tissue imaging. , 2001, Circulation.

[30]  N. Silverman,et al.  Maternal Anti-Ro and Anti-La Antibody–Associated Endocardial Fibroelastosis , 2002, Circulation.

[31]  Robert M Hamilton,et al.  Outcome of children with fetal, neonatal or childhood diagnosis of isolated congenital atrioventricular block. A single institution's experience of 30 years. , 2002, Journal of the American College of Cardiology.

[32]  R T Wakai,et al.  Magnetocardiographic Rhythm Patterns at Initiation and Termination of Fetal Supraventricular Tachycardia , 2003, Circulation.

[33]  J. Simpson,et al.  Review of diagnosis, treatment, and outcome of fetal atrial flutter compared with supraventricular tachycardia , 2003, Heart.

[34]  C. Boutin,et al.  Management of fetal tachyarrhythmia based on superior vena cava/aorta Doppler flow recordings , 2003, Heart.

[35]  B. Cuneo,et al.  Amiodarone Therapy for Drug-Refractory Fetal Tachycardia , 2004, Circulation.

[36]  K. Bremme,et al.  Signs of first-degree heart block occur in one-third of fetuses of pregnant women with anti-SSA/Ro 52-kd antibodies. , 2004, Arthritis and rheumatism.

[37]  E. Jaeggi,et al.  Fetal brady- and tachyarrhythmias: new and accepted diagnostic and treatment methods. , 2005, Seminars in fetal & neonatal medicine.

[38]  H. Shiraishi,et al.  Clinical course of fetal congenital atrioventricular block in the Japanese population: a multicentre experience , 2005, Heart.

[39]  F. Prefumo,et al.  Evaluation of fetal arrhythmias from simultaneous pulsed wave Doppler in pulmonary artery and vein , 2006, Heart.

[40]  J. Kingdom,et al.  Assessment of fetal atrioventricular time intervals by tissue Doppler and pulse Doppler echocardiography: normal values and correlation with fetal electrocardiography , 2006, Heart.

[41]  R. Wakai,et al.  Electrophysiological characteristics of fetal atrioventricular block. , 2008, Journal of the American College of Cardiology.

[42]  Mimi Y. Kim,et al.  Utility of Cardiac Monitoring in Fetuses at Risk for Congenital Heart Block: The PR Interval and Dexamethasone Evaluation (PRIDE) Prospective Study , 2008, Circulation.

[43]  V. Aiello,et al.  Perinatal Outcome of Fetal Atrioventricular Block: One-Hundred-Sixteen Cases From a Single Institution , 2008, Circulation.

[44]  H. Sago,et al.  Outcome of Prenatally Diagnosed Isolated Congenital Complete Atrioventricular Block Treated with Transplacental Betamethasone or Ritodrine Therapy , 2008, Pediatric Cardiology.